Serum bactericidal action and activation of the classic and alternate complement pathways by Neisseria gonorrhoeae.
about
Infections of People with Complement Deficiencies and Patients Who Have Undergone SplenectomyParticipation of normal human immunoglobulins M, G, and A in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by human polymorphonuclear leukocytes.Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection.Interaction of Neisseria gonorrhoeae with classical complement components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigenMeningococcal group W-135 and Y capsular polysaccharides paradoxically enhance activation of the alternative pathway of complement.Fusion protein comprising factor H domains 6 and 7 and human IgG1 Fc as an antibacterial immunotherapeuticProperdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding protein.Utilizing CMP-Sialic Acid Analogs to Unravel Neisseria gonorrhoeae Lipooligosaccharide-Mediated Complement Resistance and Design Novel Therapeutics.Dissemination of gonococcal infection is associated with delayed stimulation of complement-dependent neutrophil chemotaxis in vitro.Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae.Defining targets for complement components C4b and C3b on the pathogenic neisseriaeThe meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistanceInteraction of complement with Neisseria meningitidis and Neisseria gonorrhoeaeProperdin in complement activation and tissue injury.Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae.Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeutics.Vibrio vulnificus (lactose-positive vibrio) and Vibrio parahaemolyticus differ in their susceptibilities to human serumRequirements of immunoglobulin and the classical and alternative complement pathways for phagocytosis and intracellular killing of multiple strains of Gram-negative aerobic bacilli
P2860
Q28972389-9282A4C0-80D1-43D5-91CD-C5583DDEBE74Q33903294-A2B945BB-52D3-4BA7-8E69-3A06A477E16AQ34144667-F2EDFED6-169E-4FA7-A177-E4DA85DEAD7DQ34565599-74B07D20-2743-4C54-A1A4-783198DF8D1CQ34624357-7408E31E-DBEB-4917-A24D-5F1F7322D8CBQ34701344-80AD2C0A-7524-4300-9239-8A568F8FA32BQ35850975-5BB00AD5-5B56-446D-B523-A57B7B3FDB78Q35859218-2F6AD44B-52ED-4403-AEE6-182A310659CBQ36337334-1941D1D1-ED4D-4E53-BAB5-10894EA31605Q36376189-2F655EC1-6E9A-41B0-B687-3129B21644EDQ36422066-3B29F614-53FE-4625-BD56-0DD161868495Q36470692-962D74DE-F16F-4965-8D2F-6911B2FBABB5Q36633889-130C29BA-6EC1-467E-AD96-4E3654C83655Q38118454-C6298AB8-A193-46CC-967B-9E84FCBDA44DQ38864097-1918EC45-D5B4-4059-B1FE-40239DD64299Q40162311-7ABD6A14-5585-4344-922A-1346A30675F0Q40231165-F90E916E-83A7-4586-9061-A42B5F3183B1Q40614881-897AB0F9-A388-43C2-B8CF-DC00F7C73016Q40878195-196E68E1-780A-40A3-B7DB-077A5860C7C5
P2860
Serum bactericidal action and activation of the classic and alternate complement pathways by Neisseria gonorrhoeae.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Serum bactericidal action and ...... ways by Neisseria gonorrhoeae.
@en
Serum bactericidal action and ...... ways by Neisseria gonorrhoeae.
@nl
type
label
Serum bactericidal action and ...... ways by Neisseria gonorrhoeae.
@en
Serum bactericidal action and ...... ways by Neisseria gonorrhoeae.
@nl
prefLabel
Serum bactericidal action and ...... ways by Neisseria gonorrhoeae.
@en
Serum bactericidal action and ...... ways by Neisseria gonorrhoeae.
@nl
P2093
P1476
Serum bactericidal action and ...... ways by Neisseria gonorrhoeae.
@en
P2093
P304
P577
1978-08-01T00:00:00Z